Mastocytoma and juvenile xanthogranuloma in children

The growing number of children with rare diseases such as cutaneous mastocytoma and juvenile xanthogranuloma turning to dermatologists, as well as their clinical similarity, dictate the need for specialists to pay careful attention to these diseases. cutaneous mastocytoma is a clinical form of cutaneous mastocytosis. According to the WHO classification (2022), isolated (one focus) and multiple cutaneous mastocytoma (no more than three foci) are distinguished. juvenile xanthogranuloma belongs to the group of non-Langerhans cell histiocytosis, a broad group of related diseases characterized by the proliferation of histiocytes other than Langerhans cells. We describe a case of an unusual clinical course of solitary juvenile xanthogranuloma in a 3-year-old boy referred to Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology with suspected cutaneous mastocytoma. The size, unusual shape, localization of the lesion and elevated levels of serum tryptase exceeding the age norm (<5 μg/l) determined the atypicality of this case. Dermoscopic examination revealed a central deep yellow coloration of the lesion in the center (the setting sun symptom), a vascular pattern and a clouds symptom. Pathological examination confirmed the diagnosis of juvenile xanthogranuloma. The article also reflects the results of a dynamic observation of a child with an isolated large-sized cutaneous mastocytoma. During the examination, an increase in tryptase levels (>20 μg/l), and AST values, as well as ultrasound signs of hepatomegaly were revealed. Features of the dermoscopic and pathomorphological picture demonstrated patterns characteristic of infiltration and increased activity of mast cells. Cutaneous mastocytoma and juvenile xanthogranuloma are rare and benign skin diseases that usually begin in childhood. Diagnosis of rare diseases often requires complex differential diagnosis. Features of the modern course of cutaneous mastocytoma and juvenile xanthogranuloma are an atypical clinical picture and a high risk of developing extracutaneous symptoms. The presented clinical cases demonstrate the need for interdisciplinary monitoring of patients with these diseases and change the stereotypes of treating them as independent and regressive processes without a trace.

1. Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022;36(7):1703–1719. https://doi.org/10.1038/s41375-022-01613-1.

2. Kasikhina EI, Potekaev NN, Ivanova MA, Zhukova OV, Novozhilova OL, Ostretsova MN, Okenaeva A. Clinical and epidemiological features of cutaneous mastocytosis among the pediatric population of Moscow. Russian Journal of Allergy. 2024;21(1):74–81. (In Russ.) https://doi.org/10.36691/RJA16906.

3. Höck M, Zelger B, Schweigmann G, Brunner B, Zelger B, Kropshofer G, Kiechl-Kohlendorfer U. The various clinical spectra of juvenile xanthogranuloma: imaging for two case reports and review of the literature. BMC Pediatr. 2019;19(1):128. https://doi.org/10.1186/s12887-019-1490-y.

4. Yarovoy AA, Golubeva OV, Kleyankina SS, Yanchenko TV. Juvenile xanthogranuloma of the eye. Russian Annals of Ophthalmology. 2018;134(1):89–96. (In Russ.) https://doi.org/10.17116/oftalma2018134189-96.

5. Janssen D, Harms D. Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry. Am J Surg Pathol. 2005;29(1):21–28. https://doi.org/10.1097/01.pas.0000147395.01229.06.

6. Hernández-San Martín MJ, Vargas-Mora P, Aranibar L. Juvenile Xanthogranuloma: An Entity With a Wide Clinical Spectrum. Actas Dermosifiliogr (Engl Ed). 2020;111(9):725–733. https://doi.org/10.1016/j.ad.2020.07.004.

7. Potekaev NN, Kasikhina EI, Kochetkov MA, Zhukova OV, Ostretsova MN, Mednikova MA. Dermatoscopy for the cutaneous mastocytosis diagnosis in children. Russian Journal of Clinical Dermatology and Venereology. 2023;22(1):75–82. (In Russ.) https://doi.org/10.17116/klinderma20232201175.

8. Sławińska M, Kaszuba A, Lange M, Nowicki RJ, Sobjanek M, Errichetti E. Dermoscopic Features of Different Forms of Cutaneous Mastocytosis: A Systematic Review. J Clin Med. 2022;11(16):4649. https://doi.org/10.3390/jcm11164649.

9. Xu J, Ma L. Dermoscopic Patterns in Juvenile Xanthogranuloma Based on the Histological Classification. Front Med (Lausanne). 2021;7:618946. https://doi.org/10.3389/fmed.2020.618946.

10. Sandell RF, Carter JM, Folpe AL. Solitary (juvenile) xanthogranuloma: a comprehensive immunohistochemical study emphasizing recently developed markers of histiocytic lineage. Hum Pathol. 2015;46(9):1390–1397. https://doi.org/10.1016/j.humpath.2015.05.025.

11. Sperr WR, Stehberger B, Wimazal F, Baghestanian M, Schwartz LB, Kundi M et al. Serum tryptase measurements in patients with myelodysplastic syndromes. Leuk Lymphoma. 2002;43(5):1097–1105. https://doi.org/10.1080/10428190290021470.

12. Tran DT, Jokinen CH, Argenyi ZB. Histiocyte-rich pleomorphic mastocytoma: an uncommon variant mimicking juvenile xanthogranuloma and Langerhans cell histiocytosis. J Cutan Pathol. 2009;36(11):1215–1220. https://doi.org/10.1111/j.1600-0560.2009.01257.x.

13. Ishida M, Iwai M, Kagotani A, Iwamoto N, Okabe H. Cutaneous mastocytosis with abundant eosinophilic infiltration: a case report with review of the literature. Int J Clin Exp Pathol. 2014;7(5):2695–2697. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069928/.

14. Brockow K, Bent RK, Schneider S, Spies S, Kranen K, Hindelang B et al. Challenges in the Diagnosis of Cutaneous Mastocytosis. Diagnostics (Basel). 2024;14(2):161. https://doi.org/10.3390/diagnostics14020161.

15. Alvarez-Twose I, Vañó-Galván S, Sánchez-Muñoz L, Morgado JM, Matito A, Torrelo A et al. Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. Allergy. 2012;67(6):813–821. https://doi.org/10.1111/j.1398-9995.2012.02812.x.